Last checked at 
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Great Western Mining Corp PLC - gold, silver and copper explorer and developer in US state of Nevada - Says 12 holes at OMCO intersect elevated gold grades with the tailings thicker than expected. Says a total of 67 individual assays were examined with average grades of 1.25 grams per tonne, in a range of 0.17 to 3.76 grams per tonne. "The independent assay results of this large volume of pre-mined material are far ahead of our expectations and an important milestone in establishing the basis for a commercial processing operation on a much larger scale than envisaged at Mineral Jackpot alone. We are carefully reviewing processing options, including contained cyanide leaching, and looking at the potential economies of creating a combined facility for the processing of OMCO tailings and the spoil material from the Mineral Jackpot claims. We will keep shareholders informed at every stage," Chair Brian Hall says.
----------
GCP Student Living PLC - London-focused student accommodation investor - Says Competition & Markets Authority has decided not to refer GCP's takeover by Gemini Jersey JV LP to a phase 2 investigation. GCP agreed to a GBP969 million takeover back in July from a consortium which includes student accommodation provider Scape Living and also iQSA Holdco. Scape is funded by funds managed by APG, an investor in GCP, and iQSA by funds advised by Blackstone. At the beginning of November, company said it expects acquisition to complete before 2021 end. iQSA Holdco Ltd noted the decision.
----------
Guild Esports PLC - London-based esports company - Signs Nicolas Villalba, or Nicolas99fc, as the newest member of its football game FIFA roster. "Nicolas, from Argentina, has ranked in the top 3 FIFA players worldwide since 2018 and is Argentina's second highest earner within esports, with USD290,000 in lifetime earnings to date. His most notable international major wins include the FIFA 19 PS4 Playoffs and the FIFA 19 eClub World Cup," company notes.
----------
Yew Grove REIT PLC - invests in Irish office and industrial properties outside Dublin's central business district - Quanta Capital Asset Management Ltd, in conjunction with investment manager Davy, confirms that Goldstein Property ICAV, a 4.2% shareholder in Yew Grove, does not intend to make an offer for Yew Grove. On Friday, Quanta confirmed it will not make an offer for Yew Grove, after expressing interest in late November. Earlier in November, Yew Grove accepted a EUR127.8 million cash takeover offer from Slate Office Ireland Investment Ltd, an indirect subsidiary of Slate Office REIT. Slate offered EUR1.017 per share, plus the 1.20 cents dividend declared by Yew Grove for the third quarter.
----------
Foresight Sustainable Forestry Co PLC - forestry investment trust, managed by private equity firm Foresight Group LLP - Notes completion of two acquisitions of substantial new afforestation opportunities in Scotland. Blackmead Forestry II Ltd, which the company has an option to acquire, has fully completed the purchase of two "substantial and ideally located" afforestation opportunities in Dumfries and Galloway. "The acquisition of these sites cements two more substantial afforestation opportunities within our target seed portfolio that will both drive attractive risk-adjusted returns for investors, whilst also directly contributing to the fight against the twin threats of climate change and biodiversity loss," company says.
----------
Redx Pharma PLC - Cheshire-based cancer and fibrosis drug developer - Announces strategic partnership with molecular science and technology company Texas-based Caris Life Sciences to hasten phase 2 study recruitment in the US. "The partnership will leverage Caris' comprehensive whole transcriptome sequencing and whole exome sequencing platform assay, real-world data and its right-in-time clinical trial solutions to enhance the speed of US accruals for Redx's Phase 2 trial for the investigational Porcupine inhibitor, RXC004, in genetically-selected patients with Wnt-ligand dependent microsatellite stable metastatic colorectal cancer," company says.
----------
Poolbeg Pharma PLC - London-based clinical stage infectious disease pharmaceutical company - Inks option agreement with University College Dublin for a melioidosis vaccine candidate, MelioVac, and a licence to evaluate five other infectious disease portfolio assets. "The company will continue its due diligence on MelioVac, a preclinical asset and recipient of a Wellcome Trust award to aid its development, as well as five of other potential vaccine candidates discovered by Associate Professor McClean and her team, for the duration of the option agreement, prior to signing a licence agreement," company says. Associate Professor Siobhan McClean is the inventor of MelioVac. Says it has identified melioidosis as an infectious disease of interest due to its rising incidence around the world and because there is currently no approved vaccine available. "Concerns are growing about global warming contributing to the spread of the disease to traditionally non-tropical areas," it says.
----------
Journeo PLC - Ashby-de-la-Zouch, England-based information systems and transport technical services firm - Nets a public transport information systems contract for the supply of its displays technology and software in North Wales. Contract is worth GBP800,000. "The breadth of display technologies, stretching from ultra-low power ePaper displays suitable for rural locations where authorities cannot deliver power to the display location, to full-colour LED displays suitable for high-traffic transport corridors, will be managed using the company's content management software," company says.
----------
Distribution Finance Capital Holdings PLC - Manchester-based bank providing personal savings products - Expects full year financial performance to be in line with the board's expectations. Expects its loan book to close the year in the range of GBP250 million to GBP275 million. Loan book is at GBP243 million at November 30, up from GBP202 million at end-September, and more than doubling since the start of the year. Expects to announce its full year end trading update during the middle of January 2022.
----------
Beowulf Mining PLC - developing Kallak iron ore project and the Aitolampi natural flake graphite project - Says Finnish subsidiary Grafintec Oy signs joint venture with Epsilon Advanced Materials Private Ltd, a subsidiary of India-based manufacturer of coal tar derivatives Epsilon Carbon Private Ltd. JV is for the establishment of an anode materials production facility to be located in Finland. The JV will supply battery and cell manufacturing companies in Europe, complementing Epsilon Advanced Materials' growing anode materials business in India. Grafintec will own 49% of the JV.
----------
Okyo Pharma Ltd - London-based biotechnology firm focused on dry eye diseases and chronic pain - Expects to file IND in the third quarter of next year for OK-101 in the treatment of dry eye disease. OK-101 is the company's lead pre-clinical compound and a novel long-acting, G protein-coupled receptor-based anti-inflammatory drug candidate. OK-101 is anticipated to start human studies with a Phase 2 clinical trial in DED patients in the fourth quarter of 2022. The trial is anticipated to be conducted in approximately 100 to 200 DED patients. "Based on the anti-inflammatory response seen in pre-clinical models, this novel mechanism of action may prove to be a breakthrough treatment for the over 700 million DED patients globally," company says.
----------
SolGold PLC - Brisbane, Australia-based developer of copper-gold deposits in Ecuador - Says drill holes 14 to 22 at Cacharposa intersect mineralisation in Ecuador at the Porvenir held by subsidiary Green Rock Resources SA. Says work is advancing on a maiden mineral resource estimate for the Cacharposa deposit that is expected later this month. Drilling is ongoing with three drill rigs on site testing mineralisation. "Results from Cacharposa continue to improve with Hole 19 representing one of the best intersections to date at the Porvenir project. Mineralisation in this hole commenced from surface and attests to the economic potential of this project. Cacharposa continues to grow and with numerous other nearby mineralised targets identified, we believe the Porvenir project has the potential to become a Tier 1 copper - gold porphyry camp," says Head of Exploration Jason Ward.
----------
By Greg Roxburgh; gregroxburgh@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
